Numeric Investors’s Puma Biotechnology PBYI Stock Holding History

Numeric Investors’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-37,200	Closed	-$1.14M	–	1123
2016 Q4	$1.14M	Buy	+37,200	New	+$1.61M	0.01%	626
2016 Q2	–	Sell	-8,000	Closed	-$235K	–	1129
2016 Q1	$235K	Buy	+8,000	New	+$361K	﹤0.01%	905
2015 Q1	–	Sell	-3,800	Closed	-$719K	–	997
2014 Q4	$719K	Sell	3,800 -2,300	-38%	-$510K	0.01%	525
2014 Q3	$1.46M	Sell	6,100 -114,100	-95%	-$23.4M	0.02%	378
2014 Q2	$7.93M	Buy	120,200 +113,540	+1,705%	+$8.07M	0.12%	179
2014 Q1	$694K	Buy	+6,660	New	+$783K	0.01%	510
2013 Q4	–	Sell	-11,455	Closed	-$615K	–	852
2013 Q3	$615K	Sell	11,455 -7,500	-40%	-$404K	0.01%	537
2013 Q2	$841K	Buy	+18,955	New	+$668K	0.02%	432

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Numeric Investors's PBYI Position: Q1 2017 in Review

Numeric Investors sold out of Puma Biotechnology (PBYI) in Q1 2017, closing a stake of 37,200 shares — an estimated $1.14M sold.

Numeric Investors first reported a position in PBYI in Q2 2013 and held it in 8 quarters. The position peaked at $7.93M in Q2 2014. 136 funds tracked by Wall St. Rank hold PBYI as of Q1 2017.

Numeric Investors reported no remaining Puma Biotechnology position as of Q1 2017 after selling out during the quarter.
Numeric Investors sold 37,200 Puma Biotechnology shares in Q1 2017, an estimated $1.14M.
Numeric Investors first reported a position in Puma Biotechnology in Q2 2013 and held it in 8 quarters.
Numeric Investors's Puma Biotechnology position peaked at $7.93M in Q2 2014.
136 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2017.

Based on Numeric Investors's 13F filing for Q1 2017, filed 15 May 2017.